| 前收市價 | 5.45 |
| 開市 | 5.47 |
| 買盤 | 0.00 x 1300 |
| 賣出價 | 5.43 x 800 |
| 今日波幅 | 4.86 - 5.73 |
| 52 週波幅 | 4.86 - 22.49 |
| 成交量 | |
| 平均成交量 | 452,166 |
| 市值 | 57.091M |
| Beta 值 (5 年，每月) | 1.59 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -6.23 |
| 業績公佈日 | 2024年5月09日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 35.25 |
ZacksBlueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
Blueprint (BPMC) gains from better-than-expected first-quarter 2024 results, driven by robust Ayvakit sales growth. The company raises its revenue guidance for 2024.
ZacksZoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares rise.
ZacksNovo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
Novo Nordisk (NVO) reports better-than-expected first-quarter results, beating both earnings and revenues, driven by strong sales of Diabetes and Obesity care products.
